Severe pulmonary haemorrhage accompanying hepatorenal failure in fulminant leptospirosis

International Journal of Clinical Practice

Volumn 61, Issue 1, 2007, Pages 164-167

  Dursun, Belda ^a   Bostan, F ^b   Artac, M ^b   Varan, H I ^b   Suleymanlar, G ^b  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; FRESH FROZEN PLASMA; INOTROPIC AGENT; METHYLPREDNISOLONE; SULTAMICILLIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; ELECTROCARDIOGRAM; HEMODIALYSIS; HEPATORENAL SYNDROME; HUMAN; LABORATORY TEST; LEPTOSPIROSIS; LUNG HEMORRHAGE; MALE; PHYSICAL EXAMINATION; PLASMAPHERESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; THORAX RADIOGRAPHY; URINALYSIS;

EID: 33847082497     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.00638.x     Document Type: Article

References (31)

1. Farr RW. Leptospirosis. Clin Infect Dis 1995; 21: 1-8.
2. Bharti AR, Nally JE, Ricaldi JN et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003; 3: 757-71.
3. Yersin C, Bovet P, Merien F et al. Human leptospirosis in the Seychelles (Indian Ocean): a population- based study. Am J Trop Med Hyg 1998; 56: 933-40.
4. Tangkanakul W, Tharmaphornpil P, Plikaytis BD et al. Risk factors associated with leptospirosis in northeastern Thailand, 1998. Am J Trop Med Hyg 2000; 63: 204-8.
5. Leblebicioglu H, Sencan I, Sunbul M et al. Weil's disease: report of 12 cases. Scand J Infect Dis 1996; 28: 637-9.
6. Dupont H, Dupont-Perdrizet D, Perie JL et al. Leptospirosis: prognostic factors associated with mortality. Clin Infect Dis 1997; 25: 720-4.
7. Azouvi P, Hostachy T, Desi M, Said G. Acute and reversible axonal polyneuropathy in post-leptospirosis. Rev Neurol 1989; 145: 805-7.
8. Panicker JN, Mammachan R, Jayakumar RV. Primary neuroleptospirosis. Postgrad Med J 2001; 77: 589-90.
9. Kirchner GI, Krug N, Bleck JS et al. Fulminant course of leptospirosis complicated by multiple organ failure. Z Gastroenterol 2001; 39: 587-92.
10. Schutt M, Gerke P, Meisel H et al. Clinical characterization of Dobrava hantavirus infections in Germany. Clin Nephrol 2001; 55: 371-4.
11. O'Neil KM, Rickman LS, Lazarus AA. Pulmonary manifestations of leptospirosis. Rev Infect Dis 1991; 13: 705-9.
12. Seghal SC, Murhekar MV, Sugunan AP. Outbreak of leptospirosis with pulmonary involvement in North Andaman. Indian J Med Res 1995; 102: 9-12.
13. Daher E, Zanetta DM, Cavalcante MB, Abdulkader RC. Risk factors for death and changing patterns in leptospirosis acute renal failure. Am J Trop Med Hyg 1999; 61: 630-4.
14. Luks AM, Lakshminarayanan S, Hirschmann JV. Leptospirosis presenting as diffuse alveolar hemorrhage: case report and literature review. Chest 2003; 123: 639-43.
15. Kishimoto M, Brown JD, Chung HH, Howman S. Leptospirosis misdiagnosed as pulmonary-renal syndrome. Am J Med Sci 2004; 328: 116-20.
16. Silva JJ, Dalston MO, Carvalho JE et al. Clinicopathological and immunohistochemical features of the severe pulmonary form of leptospirosis. Rev Soc Bras Med Trop 2002; 35: 395-9.
17. Courtin JP, Di Francia M, Du Coudec L et al. Respiratory manifestations of leptospirosis: retrospective analysis of 91 cases (1978-1994). Rev Pneumol Clin 1998; 54: 382-92.
18. Marotto PC, Nascimento CM, Eluf-Neto J et al. Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis 1999; 29: 1561-3.
19. Daher E, Nogueira CB. Evaluation of penicillin therapy in patients with leptospirosis and acute renal failure. Rev Inst Med Trop Sao Paulo 2000; 42: 327- 32.
20. Edwards CW, Nicholson GD, Hassel TA et al. Penicillin therapy in icteric leptospirosis. Am J Trop Med Hyg 1988; 39: 388-90.
21. Nicodemo AC, Duarte MI, Alves VA et al. Lung lesions in human leptospirosis: microscopic, immunohistochemical, and ultrastructural features related to thrombocytopenia. Am J Trop Med Hyg 1997; 56: 181-7.
22. Alves VA, Gayotto LC, De Brito T et al. Leptospiral antigens in the liver of experimentally infected guinea pig and their relation to the morphogenesis of liver damage. Exp Toxicol Pathol 1992; 44: 425-34.
23. Alves VA, Gayotto LC, Yasuda PH et al. Leptospiral antigens (L. interrogans serogroup icterohaemorrhagiae) in the kidney of experimentally infected guinea pigs and their relation to the pathogenesis of the renal injury. Exp Pathol 1991; 42: 81-93.
24. Yang CW,WuMS, PanMJ. Leptospirosis renal disease. Nephrol Dial Transplant 2001; 16 (Suppl. 5): 73-7.
25. Stephens KE, Ishizaka A, Larrick JW, Raffin TA. Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury. Am Rev Respir Dis 1988; 137: 1364-70.
26. Tajiki MH, Salomao R. Association of plasma levels of tumor necrosis factor alpha with severity of disease and mortality among patients with leptospirosis. Clin Infect Dis 1996; 23: 1177-8.
27. Courtin JP, Carre P, Poubeau P et al. Diffuse alveolar hemorrhage and myositis in the course of leptospirosis icterohemorrhagica. Rev Mal Respir 1994; 11: 601-3.
28. Landini S, Coli U, Lucatello S, Bazatto G. Plasma exchange in severe leptospirosis. Lancet 1981; 2: 1119-20.
29. Tse KC, Yip PS, Hui KM et al. Potential benefit of plasma exchange in treatment of severe icteric leptospirosis complicated by acute renal failure. Clin Diagn Lab Immunol 2002; 9: 482-4.
30. Kahn JB. A case of Weil's disease requiring therapy for thrombocytopenia and bleeding. Am J Trop Med Hyg 1982; 31: 1213-5.
31. Auphan N, Didonate JA, Rosette C et al. Immunosuppression by glucocorticoids: inhibition of NF kappa B activation through induction of I kappa B synthesis. Science 1995; 270: 286-90.